L-Carnitine Administration in Early Sepsis

NCT01193777 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

31

Enrollment

OTHER

Sponsor class

Stopped Study stopped to open expanded phase II study

Conditions

Septic Shock

Interventions

DRUG: L-Carnitine
DRUG: Normal Saline

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]